Other
Debt Instrument, Fair Value Disclosure
Merck & Co. Debt Instrument, Fair Value Disclosure decreased by 2.0% to $44.70B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 46.1%, from $30.60B to $44.70B. Over 5 years (FY 2020 to FY 2025), Debt Instrument, Fair Value Disclosure shows an upward trend with a 4.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 4, 2026
How to read this metric
If the fair value is significantly lower than the carrying amount, it may indicate an opportunity to repurchase debt at a discount or reflect rising market interest rates.
Detailed definition
This represents the estimated fair market value of the company's total debt obligations, which may differ from the carry...
Peer comparison
Publicly traded companies with significant bond issuances are required to disclose this to show the market's current valuation of their credit risk.
Metric ID:
other_debt_instrument_fair_valueHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $29.50B | $29.10B | $35.70B | $31.70B | $29.00B | $25.90B | $26.70B | $28.20B | $34.00B | $29.50B | $32.00B | $30.40B | $33.50B | $35.20B | $32.60B | $30.60B | $31.30B | $37.70B | $45.60B | $44.70B |
| QoQ Change | — | -1.4% | +22.7% | -11.2% | -8.5% | -10.7% | +3.1% | +5.6% | +20.6% | -13.2% | +8.5% | -5.0% | +10.2% | +5.1% | -7.4% | -6.1% | +2.3% | +20.4% | +21.0% | -2.0% |
| YoY Change | — | — | — | — | -1.7% | -11.0% | -25.2% | -11.0% | +17.2% | +13.9% | +19.9% | +7.8% | -1.5% | +19.3% | +1.9% | +0.7% | -6.6% | +7.1% | +39.9% | +46.1% |
Range$25.90B – $45.60B
CAGR+9.1%
Avg YoY Growth+7.3%
Median YoY Growth+4.5%
Debt Instrument, Fair Value Disclosure at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s debt instrument, fair value disclosure?
- Merck & Co. (MRK) reported debt instrument, fair value disclosure of $44.70B in Q1 2026.
- How has Merck & Co.'s debt instrument, fair value disclosure changed year-over-year?
- Merck & Co.'s debt instrument, fair value disclosure increased by 46.1% year-over-year, from $30.60B to $44.70B.
- What is the long-term trend for Merck & Co.'s debt instrument, fair value disclosure?
- Over 5 years (2020 to 2025), Merck & Co.'s debt instrument, fair value disclosure has grown at a 4.8% compound annual growth rate (CAGR), from $36.00B to $45.60B.
- What does debt instrument, fair value disclosure mean?
- The current market price to buy back or pay off the company's debt.